MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 240 filers reported holding MEDIVATION INC in Q1 2014. The put-call ratio across all filers is 1.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $30,231,000 | +48.2% | 501,335 | +13.0% | 0.06% | +52.4% |
| Q1 2016 | $20,400,000 | +20.4% | 443,680 | +26.6% | 0.04% | +27.3% |
| Q4 2015 | $16,943,000 | +78.8% | 350,493 | +57.2% | 0.03% | +73.7% |
| Q3 2015 | $9,478,000 | -22.6% | 223,008 | +108.0% | 0.02% | -17.4% |
| Q2 2015 | $12,245,000 | -2.9% | 107,222 | +9.7% | 0.02% | 0.0% |
| Q1 2015 | $12,616,000 | +26.7% | 97,747 | -2.3% | 0.02% | +35.3% |
| Q4 2014 | $9,961,000 | -49.1% | 99,997 | -49.5% | 0.02% | -51.4% |
| Q3 2014 | $19,582,000 | +164.2% | 198,058 | +105.9% | 0.04% | +169.2% |
| Q2 2014 | $7,413,000 | +111.1% | 96,179 | +76.3% | 0.01% | +116.7% |
| Q1 2014 | $3,512,000 | +63.5% | 54,566 | +62.1% | 0.01% | +50.0% |
| Q4 2013 | $2,148,000 | +88.4% | 33,653 | +77.0% | 0.00% | +100.0% |
| Q3 2013 | $1,140,000 | – | 19,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $186,908,000 | 79.34% |
| Redmile Group, LLC | 1,752,642 | $74,487,000 | 5.64% |
| APIS CAPITAL ADVISORS, LLC | 93,500 | $3,974,000 | 5.50% |
| March Altus Capital Management LP | 18,794 | $799,000 | 4.71% |
| HealthCor Management, L.P. | 1,900,000 | $80,750,000 | 4.55% |
| BB BIOTECH AG | 2,581,112 | $109,697,000 | 3.48% |
| Selkirk Management LLC | 116,000 | $4,930,000 | 3.06% |
| Opus Point Partners Management, LLC | 118,372 | $5,031,000 | 2.78% |
| TORRAY INVESTMENT PARTNERS LLC | 797,015 | $33,873,000 | 2.49% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 3,772,600 | $160,336,000 | 1.78% |